Aza-arylpiperazines

The present invention refers to chemical compounds of formula (I), as well as pharmaceutically acceptable salts, solvates and esters thereof, wherein R1 to R4 have the significance given in claim 1. They can be used in the form of pharmaceutical preparations for the treatment or prevention of disord...

Full description

Saved in:
Bibliographic Details
Main Authors HANS RICHTER, STEPHAN ROEVER, SVEN TAYLOR, JONATHAN RICHARD ANTHONY ROFFEY, ADAMS, DAVID REGINALD, BLENCH, TOBY JONATHAN, HEBEISEN, PAUL, BENTLEY, JONATHAN MARK, MONCK, NATHANIEL JULIUS THOMAS
Format Patent
LanguageChinese
English
Published 16.12.2003
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The present invention refers to chemical compounds of formula (I), as well as pharmaceutically acceptable salts, solvates and esters thereof, wherein R1 to R4 have the significance given in claim 1. They can be used in the form of pharmaceutical preparations for the treatment or prevention of disorders of the central nervous system, damage to the central nervous system, cardiovascular disorders, gastrointestinal disorders, diabetes, obesity and sleep apnoea.
AbstractList The present invention refers to chemical compounds of formula (I), as well as pharmaceutically acceptable salts, solvates and esters thereof, wherein R1 to R4 have the significance given in claim 1. They can be used in the form of pharmaceutical preparations for the treatment or prevention of disorders of the central nervous system, damage to the central nervous system, cardiovascular disorders, gastrointestinal disorders, diabetes, obesity and sleep apnoea.
Author STEPHAN ROEVER
BLENCH, TOBY JONATHAN
HANS RICHTER
BENTLEY, JONATHAN MARK
HEBEISEN, PAUL
MONCK, NATHANIEL JULIUS THOMAS
JONATHAN RICHARD ANTHONY ROFFEY
SVEN TAYLOR
ADAMS, DAVID REGINALD
Author_xml – fullname: HANS RICHTER
– fullname: STEPHAN ROEVER
– fullname: SVEN TAYLOR
– fullname: JONATHAN RICHARD ANTHONY ROFFEY
– fullname: ADAMS, DAVID REGINALD
– fullname: BLENCH, TOBY JONATHAN
– fullname: HEBEISEN, PAUL
– fullname: BENTLEY, JONATHAN MARK
– fullname: MONCK, NATHANIEL JULIUS THOMAS
BookMark eNrjYmDJy89L5WQQdqxK1E0sqswpyCxILUqsysxLLeZhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfEh4UYGBsYG5mYWxo7GxKgBAAXYIpE
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID TW200307683A
GroupedDBID EVB
ID FETCH-epo_espacenet_TW200307683A3
IEDL.DBID EVB
IngestDate Fri Jul 19 14:21:02 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Chinese
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_TW200307683A3
Notes Application Number: TW200392101825
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20031216&DB=EPODOC&CC=TW&NR=200307683A
ParticipantIDs epo_espacenet_TW200307683A
PublicationCentury 2000
PublicationDate 20031216
PublicationDateYYYYMMDD 2003-12-16
PublicationDate_xml – month: 12
  year: 2003
  text: 20031216
  day: 16
PublicationDecade 2000
PublicationYear 2003
RelatedCompanies F. HOFFMANN-LA ROCHE AG
VERNALIS RESEARCH LIMITED
RelatedCompanies_xml – name: F. HOFFMANN-LA ROCHE AG
– name: VERNALIS RESEARCH LIMITED
Score 2.6854692
Snippet The present invention refers to chemical compounds of formula (I), as well as pharmaceutically acceptable salts, solvates and esters thereof, wherein R1 to R4...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Aza-arylpiperazines
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20031216&DB=EPODOC&locale=&CC=TW&NR=200307683A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSUkyNEw2BO1uNwJGg0lqcqJukkVSkq6FkXGiabKZcYoF-Lo3Xz8zj1ATrwjTCCaGLNheGPA5oeXgwxGBOSoZmN9LwOV1AWIQywW8trJYPykTKJRv7xZi66IG6x0bGxoZmqm5ONm6Bvi7-DurOTvbhoSr-QWB5UCTTsaOzAyswGa0OSg3uIY5gXalFCBXKW6CDGwBQNPySoQYmKoyhBk4nWE3rwkzcPhCJ7yBTGjeKxZhEHasStRNLKrMKcgsSC0CnwpdLMqg6OYa4uyhCzQ9Hu6V-JBwhEOMxRhYgF38VAkGhdQUo0Rjk9REIwtTc5NUy0RgI8LI0jw10TLNNM0kMclMkkEKtzlS-CSlGbggy8-MdA3NZBhYSopKU2WB1WhJkhzY_wDnR3YE
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSUkyNEw2BO1uNwJGg0lqcqJukkVSkq6FkXGiabKZcYoF-Lo3Xz8zj1ATrwjTCCaGLNheGPA5oeXgwxGBOSoZmN9LwOV1AWIQywW8trJYPykTKJRv7xZi66IG6x0bGxoZmqm5ONm6Bvi7-DurOTvbhoSr-QWB5UCTTsaOzAysQNoclBtcw5xAu1IKkKsUN0EGtgCgaXklQgxMVRnCDJzOsJvXhBk4fKET3kAmNO8VizAIO1Yl6iYWVeYUZBakFoFPhS4WZVB0cw1x9tAFmh4P90p8SDjCIcZiDCzALn6qBINCaopRorFJaqKRham5SaplIrARYWRpnppomWaaZpKYZCbJIIXbHCl8kvIMnB4hvj7xPp5-3tIMXJClaEa6hmYyDCwlRaWpssAqtSRJDhwWAJprePc
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Aza-arylpiperazines&rft.inventor=HANS+RICHTER&rft.inventor=STEPHAN+ROEVER&rft.inventor=SVEN+TAYLOR&rft.inventor=JONATHAN+RICHARD+ANTHONY+ROFFEY&rft.inventor=ADAMS%2C+DAVID+REGINALD&rft.inventor=BLENCH%2C+TOBY+JONATHAN&rft.inventor=HEBEISEN%2C+PAUL&rft.inventor=BENTLEY%2C+JONATHAN+MARK&rft.inventor=MONCK%2C+NATHANIEL+JULIUS+THOMAS&rft.date=2003-12-16&rft.externalDBID=A&rft.externalDocID=TW200307683A